KBA1412

· Kling Biotherapeutics B.V.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for KBA1412, covering 2025-09-25 to 2025-09-25. Get the full timeline:

Most recent: Clinical Trial Update: Study of KBA1412 in Participants With Advanced Solid Malignant Tumors [Phase 1]